Effects of Dapagliflozin on Hormonal Glucose Homeostasis in Type 1 Diabetes
Clinical trial NCT04035031 · COMPLETED
Trial details
- NCT number
- NCT04035031
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-09
- Primary completion
- 2020-11-12
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.